Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - 65 |
| Updated: | 1/13/2019 |
| Start Date: | March 3, 2017 |
| End Date: | December 24, 2018 |
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
It is well established in the scientific literature that people with schizophrenia smoke
tobacco cigarettes at rates up to three times that of the general population, relapse more
frequently, and die an average of 25 years earlier from cigarette smoking and other
life-style attributable illnesses. Electronic cigarettes (e-cigarettes) are becoming
increasingly popular with smokers worldwide and new research suggests that e-cigarettes are
appealing to smokers with schizophrenia. There is a paucity of research focused on the
experience of smokers with schizophrenia who decide to try an e-cigarette. A well-designed
prospective-observational study is needed to learn more about the influence of e-cigarette
use on cigarette smoking behavior and mental and physical health among smokers with
schizophrenia. In response, the investigators have designed a study titled, Role of an
electronic cigarette on smoking displacement in smokers with schizophrenia: A prospective
3-month pilot study (SchizEcig).
tobacco cigarettes at rates up to three times that of the general population, relapse more
frequently, and die an average of 25 years earlier from cigarette smoking and other
life-style attributable illnesses. Electronic cigarettes (e-cigarettes) are becoming
increasingly popular with smokers worldwide and new research suggests that e-cigarettes are
appealing to smokers with schizophrenia. There is a paucity of research focused on the
experience of smokers with schizophrenia who decide to try an e-cigarette. A well-designed
prospective-observational study is needed to learn more about the influence of e-cigarette
use on cigarette smoking behavior and mental and physical health among smokers with
schizophrenia. In response, the investigators have designed a study titled, Role of an
electronic cigarette on smoking displacement in smokers with schizophrenia: A prospective
3-month pilot study (SchizEcig).
This is a prospective 3 month pilot study to observe cigarette use behavior among people with
a schizophrenia spectrum disorder diagnosis who smoke conventional tobacco cigarettes, do not
intend to reduce or quit smoking, and are invited to use an e-cigarette. The investigators
are interested to know if e-cigarette use is associated with cigarette smoking displacement.
Displacement is defined as switching from conventional tobacco cigarettes to e-cigarettes.
The investigators will also monitor for physical and mental health, including blood pressure,
weight, and scores from the Scale for the Assessment of Negative Symptoms (SANS) and the
Scale for the Assessment of Positive Symptoms (SAPS) as well as any reported adverse events
participants' feel are attributed to e-cigarette use and participants' perceptions of the
sensory experience associated with e-cigarette use.
a schizophrenia spectrum disorder diagnosis who smoke conventional tobacco cigarettes, do not
intend to reduce or quit smoking, and are invited to use an e-cigarette. The investigators
are interested to know if e-cigarette use is associated with cigarette smoking displacement.
Displacement is defined as switching from conventional tobacco cigarettes to e-cigarettes.
The investigators will also monitor for physical and mental health, including blood pressure,
weight, and scores from the Scale for the Assessment of Negative Symptoms (SANS) and the
Scale for the Assessment of Positive Symptoms (SAPS) as well as any reported adverse events
participants' feel are attributed to e-cigarette use and participants' perceptions of the
sensory experience associated with e-cigarette use.
Inclusion Criteria:
Clinical diagnosis of a schizophrenia spectrum disorder
Non-hospitalized persons
Regular smokers who report smoking 20 or more cigarettes per day who have smoked at least
100 cigarettes in their lifetime, and are not intending to reduce or quit
Has agreed to try an e-cigarette
Must be able to provide written informed consent
Must be able to read, write and communicate in English proficiently
Must have access to a computer with internet
Must have the ability to work a computer and navigate the internet easily
Exclusion Criteria:
Non-smokers Persons without a schizophrenia spectrum disorder diagnosis
Hospitalized persons
Cardio vascular disease
Respiratory disease
Use of smokeless tobacco or any other tobacco products besides cigarettes.
Use of nicotine replacement therapy or other smoking cessation pharmaco-therapies within
the last 3 months
Pregnancy or breastfeeding
We found this trial at
1
site
525 East 68th Street
New York, New York 10065
New York, New York 10065
Phone: 646-962-8313
Click here to add this to my saved trials
